You searched for "paralysis"
Why screen for hearing loss in adults?
Introduction Hearing loss affects over 10 million people in the UK – one in six of the population. Of over 50-year-olds 41.7% are estimated to have some form of hearing loss. This rises to 71.1% of over 70-year-olds, over half...Not just the scissors: the story of Myron Metzenbaum
Myron Metzenbaum was born in Cleveland, Ohio (USA) in 1876, the fourth of nine children. As a young man, he worked in the family’s linen store, where his father was well known to be very kind to the less fortunate...Changing perceptions in head and neck cancer management caused by quality of life issues
Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...
A ‘smarter’ personal amplification device
The hearing aids available on the market today are undeniably impressive, particularly when compared to their clunky and squeaky predecessors. At a most basic level, hearing aids sample the surrounding auditory signal in real-time, breaking sounds down into frequency-specific channels....BIOHIT HealthCare and the British Laryngological Association agree to corporate partnership
BIOHIT HealthCare is pleased to announce its corporate partnership with the British Laryngological Association (BLA) for 2022-2023, which brings together two organisations with the mission to advance laryngology diagnostics.BIOHIT HealthCare is exhibiting at the BSI congress 2022
BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.Wraparound IBD care pathway for enhanced patient outcomes
BIOHIT HealthCare is pleased to announce its partnership with Celltrion Healthcare UK Ltd, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to seamlessly support patients with inflammatory bowel disease (IBD) and their healthcare providers.
Dupilumab prospective RCT for CRSwNP, a multinational trial of 60 patients with a 16-week CT follow-up
This transcontinental work describes a randomised, double blind, placebo controlled parallel group study over a 16-week period, assessing 60 patients with CRSwNP by CT scan scores. All patients had a four-week period of intranasal corticosteroids followed by randomisation to add...
ChatGPT Quiz skills need refinement!
On 30 November 2022, ChatGPT was launched, free for all to use online. For those who are not aware, ChatGPT (Chat Generative Pre-trained Transformer) is an artificial intelligence (AI) chatbot which utilises the web to create detailed and natural human-like...VACANCY: Band 6 Senior Audiologist, Belfast
The following job opportunity is now available.
